WO2014119987A1 - Intravenous catheter of a polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence - Google Patents

Intravenous catheter of a polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence Download PDF

Info

Publication number
WO2014119987A1
WO2014119987A1 PCT/MX2014/000032 MX2014000032W WO2014119987A1 WO 2014119987 A1 WO2014119987 A1 WO 2014119987A1 MX 2014000032 W MX2014000032 W MX 2014000032W WO 2014119987 A1 WO2014119987 A1 WO 2014119987A1
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
patient
nanoparticles
oriented
intravenous
Prior art date
Application number
PCT/MX2014/000032
Other languages
Spanish (es)
French (fr)
Inventor
José Antonio Arellano Cabrera
José María Rodriguez Lelis
María Teresa Lucas Jimenez
Alfredo Chalita Vizcarra
Original Assignee
Equipos Médicos Vizcarra, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Equipos Médicos Vizcarra, S.A. filed Critical Equipos Médicos Vizcarra, S.A.
Publication of WO2014119987A1 publication Critical patent/WO2014119987A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/18Materials at least partially X-ray or laser opaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L29/126Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624Nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/10Materials for lubricating medical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/0045Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
    • A61M2025/0046Coatings for improving slidability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0056Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Definitions

  • the present invention is related to the hospital instrument manufacturing industry. More specifically it relates to the instrument manufacturing industry for venous canalization and the administration of medications directly into the vascular system. Even more specifically it relates to the manufacturing industry of peripheral, central and other intravenous catheters, which are made of biocompatible composite materials reinforced with nano particles. BACKGROUND OF THE INVENTION
  • IV intravenous therapy starts from the need to transfer blood from one human being to another, and dates from approximately 1492.
  • the administration of medications to the vascular system of patients by specific treatments and when the medication It will be supplied with long periods of time, it represents a challenge in the design of medication delivery systems.
  • the device most commonly used to achieve this are intravenous catheters, which are formed from a pipe with a diameter smaller than the vein where it will be inserted and are made of soft, flexible, waterproof and non-reactive materials to the medications of the selected therapy , in addition to being made of a biocompatible material with living tissues.
  • intravenous catheters are plastic materials such as silicones, polyurethanes, PVC, polytetrafluoroethylene and others; These materials are injected or extruded through a die so that pipes of different diameters are formed according to the required lumen size.
  • intravenous catheters are typically made with a radiopaque compound used to visualize the catheter during medical procedures such as a PTCA. diagnostic imaging or as security to visualize in specific cases the location of the catheter in the patient's vascular system by means of x-rays and avoid tissue damage.
  • intravenous catheters are used for intravenous administration of a fluid
  • a disposable needle that passes through the catheter is used;
  • the needle makes a cut in the patient's skin and vein and allows the catheter to enter.
  • the needle is removed leaving the intravenous catheter in place for connection to an intravenous bag or a bottle, or a cap for later use .
  • a lubricant coating is applied to the catheters on its external surface with the aim of making the puncture and placement of this device as painless as possible to the patient.
  • This lubricant coating is often a type of silicone or hydrophilic gel which becomes lubricant after absorbing water.
  • a biocompatible material to provide a low coefficient of friction is polytetrafluoroethylene, however it is a material that due to its low adhesion energies is difficult to adhere to another material and the processing and manufacturing of intravenous catheters results in a very complicated process.
  • catheters should cover are phlebitis complications [2] which may occur in percentages above 75% of hospitalized patients [3], which means a problem in clinical treatment, patient dissatisfaction, continuous catheter replacement and prolonged hospitalization stays that increase the costs of hospitalization services. Health.
  • One of the factors that causes phlebitis is related to the type of medication administered that can irritate the tissues in the catheterization zone.
  • the other factors are related to infectious agents due to the growth of microorganisms between the catheter and the puncture site.
  • mechanical factors such as the type of catheter material, site size and duration of catheterization.
  • Oligodynamic metals such as silver in the form of ions and small amounts are very effective as bactericides.
  • a collagen-shaped silver polymeric coating is used which dissolves once the catheter is in the patient's vascular system thus preventing the growth of microorganisms in the puncture site.
  • Other similar solutions can be found in patents US 005759564A, US 006060000A and others.
  • oligodynamic metals in the form of a fluid coating presents the problem that the coating dissolves very quickly and then there is no longer antibacterial protection and in most intravenous catheters their stay in the patient's vascular system is prolonged, In addition to the fact that infections can enter the patient's body through the inside or outside of the catheter and not all catheters are coated in both areas.
  • the main objective of the invention is to achieve an intravenous catheter that has a low coefficient of friction with the patient's skin and vein so as to minimize tissue damage caused by puncture and placement of the catheter.
  • Another objective is to achieve an intravenous catheter made of polymer composite material reinforced with nanoparticles oriented in specific directions, which also prevents the growth of bacterial agents causing infections or phlebitis.
  • Still another objective is an intravenous catheter that presents the mechanical properties necessary to avoid the phenomena of roll up and flourish of the catheter when the puncture is performed and its placement in the vascular system of the patient and has sufficient flexibility to adapt to the shape and movements of the vein during its time of use.
  • This invention relates to an intravenous catheter for the administration of medications or fluids to a patient's vascular system, particularly it relates to peripheral, central intravenous catheters and other types of catheters that are placed in a patient's vascular system for administration or fluid removal
  • the catheter manufacturing material is composed of a material composed of a polymeric matrix which is reinforced with nanoparticles oriented in specific directions and which is produced by means of the injection and / or extrusion of said material for the formation of a pipe that serves as a base component for catheter fabrication.
  • This invention relates to a medical device that meets the characteristics of be a catheter for their mechanical and according c to the type of orientation properties of nanoparticles, avoids phenomena arremangado and flourish of the catheter tip that is inserted into the vein of the patient through the skin by cutting a introducer needle, in addition to being a catheter that due to the composition of the material that forms it has low coefficients of friction between its exterior and the punctured skin when the patient's vascular system is placed.
  • the material from which the catheter is formed has the characteristic of being a material that prevents the growth of infectious agents in the area of catheterization of the patient avoiding the generation of phlebitis and the problems related to this condition.
  • the polymer composite composite catheter with oriented nanoparticles, low coefficient of friction and low microbial adhesion of this invention is composed of a pipe made of biocompatible polymeric material to which a percentage of biocompatible nano particles that range in ranges are added during processing 10 to 50 percent of the total material processed.
  • the nanoparticles are in ranges of sizes greater than 1 nm and oriented in specific directions, within the polymeric material by physical means, so that the resulting pipe is of a polymeric composite material with nano particles oriented in specific directions.
  • the pipe that forms the catheter is cut into sections that range in lengths greater than 1 cm, where the distal part of the catheter pipe is formed by physical means in determined geometries according to the type of medical procedure to which it will be applied; while in the anterior part of the catheter a component is attached that allows the coupling with the serum tubes for the administration of medication, with devices for the extraction of fluids and others related to catheterization procedures.
  • the base pipe for catheter fabrication can be formed in ranges of outside diameter greater than 0.1 mm and can be formed in ranges of internal diameter greater than 0.1 mm.
  • the orientation of the nanoparticles in the polymer composite material meet with two main functions; The first is to provide the catheter with mechanical resistance to flourish and roll up during the puncture and canalization process, in addition to providing the catheter with flexibility to deform depending on the movement of the patient's vein when it has already been placed.
  • the second main function is that according to the type of nanoparticles selected and the type of orientation they provide the catheter with low coefficients of friction with the patient's skin and vein, in addition to being nanoparticles with bactericidal properties, thus preventing the formation of infectious agents. in the catheterization zone. Even more nanoparticles have radiopacity properties.
  • Fig. 1 illustrates an isometric view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions.
  • Fig. 2 shows a side sectional view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions.
  • Fig. 3 illustrates a cross-sectional view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions.
  • Fig. 4 shows a side sectional view of one of the possible configurations of the distal tip of the intravenous catheter made of polymeric composite material reinforced with nanoparticles oriented in specific directions.
  • FIG. 1 An isometric view of the intravenous catheter made of polymeric composite material reinforced with nanoparticles oriented in specific directions is shown in Figure 1.
  • the pipe (1) made of polymeric composite material reinforced with nanoparticles is attached to a hub or canopy (2 ) which serves as a coupling to intravenous infusion systems or other devices depending on the particular application of the catheter, in addition the anterior part of the pipe (1) is formed by physical means in specific geometries (1 1) depending on the particular application of the catheter
  • the pipe (1) is placed inside the patient's body in the treatment areas while the pavilion (2) is outside to be coupled to the infusion systems or other medical devices necessary for the specific treatment
  • the layers that form the intravenous catheter pipe (1) made of polymer composite material reinforced with nanoparticles oriented in specific directions are shown in the side sectional view of Figure 2. Inside the pipe there is a gap or lumen (14 ) where the fluids circulate through the catheter, this lumen (14) can be formed in diameters of ranges greater than 0.1 mm.
  • the lumen wall (13) is formed of the composite polymeric material reinforced with nanoparticles, which are oriented in directions with orientation angles between 0 and 360 degrees and with a concentration in the polymer matrix with ranges between 10 and 50% of reinforcing particles.
  • a coating (12) made of particles with bactericidal properties and friction coefficients of less than 0.9.
  • the coating (12) is diffused with the surface of the lumen wall (13) formed a second compound representing the surface of the catheter pipe (1).
  • FIG. 3 A cross-sectional view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions is shown in Figure 3.
  • the layers forming the catheter tubing (1) having internal diameters or lumen (14) are indicated. in ranges greater than 0.1 mm and external diameters with ranges greater than 0.1 mm with lumen wall thicknesses (13) greater than 0.01 mm.
  • a coating (12) of a compound made of bactericidal materials with low coefficient of friction is applied in order to reduce the resistance to displacement of the catheter through the patient's tissues and besides avoiding the adhesion and microbial growth that can generate infections.
  • the lumen wall (13) is reinforced with nano particles which, through its orientation, increase the resistance of the catheter pipe (1) in the axial direction of the pipe and increase the flexibility in the transverse direction of the catheter pipe ( one).
  • a sectional view of the tip formed of the catheter pipe (1) is shown in Figure 4.
  • the pipe formed by a lumen (14) with a lumen wall (13) coated on its outside by a coating (12) in The anterior part is formed by mechanical or thermal physical means in specific geometries (11) depending on the type of treatment and application of the catheter.
  • a possible specific geometry (1 1) is that shown in Figure 4 which corresponds to a specific geometry (11) characteristic of a peripheral intravenous catheter, in which the different layers that form the catheter tubing can be observed ( 1) made of polymer composite material reinforced with nano particles oriented in specific directions.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to an intravenous catheter for administering drugs or fluids to the vascular system of a patient, and in particular relates to peripheral intravenous catheters, central intravenous catheters and other types of catheters that are placed in the vascular system of a patient in order to administer or remove fluids. The catheter is formed by a tube (1) made up of a lumen (14) with a lumen wall (13) made of a polymer matrix reinforced with nanoparticles oriented in specific directions and with a low friction coefficient; the lumen wall (13) is coated with a coating (12) made of a compound of a bactericidal material with a low friction coefficient. The catheter of polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence of the invention has the advantages of: a) reducing the forces of resistance or friction of the catheter against the tissue of the patient when the catheter is inserted; b) having compounds of bactericidal material that reduce the adherence of microorganisms on the surface of the catheter and the growth thereof, thus avoiding the generation of infections in the catheterisation areas; and c) the orientation of the reinforcing particles grants the catheter mechanical properties that provide comfort for the patient during the catheterisation procedure and all the related treatment.

Description

CATÉTER INTRAVENOSO DE MATERIAL COMPUESTO POLIMÉRICO CON NANOP ARTICULAS ORIENTADAS, DE BAJO COEFICIENTE DE  INTRAVENOUS CATHETER OF POLYMER COMPOSITE MATERIAL WITH NANOP ORIENTED ARTICLES, LOW COEFFICIENT OF
FRICCIÓN Y BAJA ADHERENCIA MICROBIANA CAMPO DE LA INVENCIÓN  FRICTION AND LOW MICROBIAL ADHERENCE FIELD OF THE INVENTION
La presente invención está relacionada con la industria de manufactura de instrumental hospitalario. Más específicamente se relaciona con la industria manufacturera de instrumentos para la canalización venosa y la administración de medicamentos directamente en el sistema vascular. Todavía más específicamente se relaciona con la industria de manufactura de catéteres intravenosos periféricos, centrales y otros, los cuales son elaborados de materiales compuestos biocompatibles reforzados con nano partículas. ANTECEDENTES DE LA INVENCIÓN The present invention is related to the hospital instrument manufacturing industry. More specifically it relates to the instrument manufacturing industry for venous canalization and the administration of medications directly into the vascular system. Even more specifically it relates to the manufacturing industry of peripheral, central and other intravenous catheters, which are made of biocompatible composite materials reinforced with nano particles. BACKGROUND OF THE INVENTION
Como mencionan Rivera y colaboradores [1], la terapia intravenosa IV parte de la necesidad de transferir sangre de un ser humano a otro, y data de aproximadamente de 1492. La administración de medicamentos al sistema vascular de pacientes por tratamientos específicos y cuando el medicamento se va a suministrar con largos periodos de tiempo, representa un reto en el diseño de sistemas de administración de medicamentos. El dispositivo de mayor uso para lograr esto, son los catéteres intravenosos, los cuales se forman de una tubería de diámetro menor a la vena donde será insertado y se elaboran de materiales suaves, flexibles, impermeables y no reactivos a los medicamentos de la terapia seleccionada, además de elaborarse de un material biocompatible con los tejidos vivos. As Rivera et al [1] mention, IV intravenous therapy starts from the need to transfer blood from one human being to another, and dates from approximately 1492. The administration of medications to the vascular system of patients by specific treatments and when the medication It will be supplied with long periods of time, it represents a challenge in the design of medication delivery systems. The device most commonly used to achieve this, are intravenous catheters, which are formed from a pipe with a diameter smaller than the vein where it will be inserted and are made of soft, flexible, waterproof and non-reactive materials to the medications of the selected therapy , in addition to being made of a biocompatible material with living tissues.
Los materiales tradicionales empleados para los catéteres intravenosos son materiales plásticos como silicones, poliuretanos, PVC, politetrafluoroetileno y otros; estos materiales se inyectan o extruden a través de un dado de manera que se forman tuberías de diferentes diámetros de acuerdo al tamaño de lumen requerido. Además los catéteres intravenosos típicamente se elaboran con un compuesto radiopaco usado para visualizar el catéter durante procedimiento médicos tales como un PTCA, procedimientos de i diagnósticos por imagen o como seguridad para visualizar en casos específicos la ubicación del catéter en sistema vascular del paciente por medio de rayos x y evitar lesiones a los tejidos. En la actualidad los catéteres intravenosos se utilizan para la administración intravenosa de un fluido, se utiliza una aguja desechable que pasa a través del catéter; la aguja realiza un corte en la piel y vena del paciente y permite la entrada del catéter. Una vez que se verifica el ensamble colocado en la vena mediante una retrospección de la sangre en la aguja, se saca la aguja dejando el catéter intravenoso en su lugar para la conexión a una bolsa intravenosa o una botella, o un tope para su uso posterior. The traditional materials used for intravenous catheters are plastic materials such as silicones, polyurethanes, PVC, polytetrafluoroethylene and others; These materials are injected or extruded through a die so that pipes of different diameters are formed according to the required lumen size. In addition, intravenous catheters are typically made with a radiopaque compound used to visualize the catheter during medical procedures such as a PTCA. diagnostic imaging or as security to visualize in specific cases the location of the catheter in the patient's vascular system by means of x-rays and avoid tissue damage. At present, intravenous catheters are used for intravenous administration of a fluid, a disposable needle that passes through the catheter is used; The needle makes a cut in the patient's skin and vein and allows the catheter to enter. Once the assembly placed in the vein is verified by a retrospection of the blood in the needle, the needle is removed leaving the intravenous catheter in place for connection to an intravenous bag or a bottle, or a cap for later use .
Además de lo anterior, algunas veces es necesario administrar sucesivamente fluidos por vía intravenosa al paciente lo que requiere que el paciente sea sometido a una serie de varias punciones intravenosas realizadas en diferentes periodos de tiempo y zonas del cuerpo, lo que resulta para el paciente en una experiencia traumática y dolorosa. Como solución a esto se aplica un recubrimiento lubricante a los catéteres en su superficie externa con el objetivo de que la punción y colocación de este dispositivo resulte lo menos dolorosa posible al paciente. Este recubrimiento lubricante con frecuencia es un tipo de gel de silicón o hidrofílicos los cuales se vuelven lubricantes después de absorber agua. Patentes como las US 7,914,809 B2, US 20080228168A1, US 6,221,461 Bl y otras presentan soluciones aplicando recubrimientos lubricantes a catéteres. Uno de los problemas comunes con los recubrimientos lubricantes que presentan alta lubricidad es su pobre adhesión a la superficie del catéter además de que se pueden perder características del catéter como son resistencia, flexibilidad y fácil fabricación. Un material biocompatible para proveer un bajo coeficiente de fricción es el politetrafluoroetileno, sin embargo es un material que por sus bajas energías de adhesión es difícil de adherir a otro material y el procesamiento y manufactura de catéteres intravenosos resulta en un proceso muy complicado. In addition to the above, it is sometimes necessary to successively administer intravenous fluids to the patient, which requires that the patient be subjected to a series of several intravenous punctures performed in different periods of time and areas of the body, which results for the patient in A traumatic and painful experience. As a solution to this, a lubricant coating is applied to the catheters on its external surface with the aim of making the puncture and placement of this device as painless as possible to the patient. This lubricant coating is often a type of silicone or hydrophilic gel which becomes lubricant after absorbing water. Patents such as US 7,914,809 B2, US 20080228168A1, US 6,221,461 Bl and others present solutions applying lubricating coatings to catheters. One of the common problems with lubricating coatings that have high lubricity is their poor adhesion to the catheter surface, in addition to catheter characteristics such as strength, flexibility and easy manufacturing. A biocompatible material to provide a low coefficient of friction is polytetrafluoroethylene, however it is a material that due to its low adhesion energies is difficult to adhere to another material and the processing and manufacturing of intravenous catheters results in a very complicated process.
Aún otra característica que deben cubrir los catéteres son las complicaciones por flebitis [2] que puede ocurrir en porcentajes arriba del 75% de los pacientes hospitalizados [3], lo que significa un problema en el tratamiento clínico, inconformidad del paciente, continuo remplazo de catéteres y estadías prolongadas de hospitalización que incrementan los costos de servicios de salud. Uno de los factores que provoca la flebitis está relacionado con el tipo de medicamento administrado que puede irritar los tejidos en la zona de cateterización. Los otros factores están relacionados con agentes infecciosos por el crecimiento de microorganismos entre el catéter y la zona de punción. Además de factores mecánicos como son el tipo de material del catéter, tamaño sitio y duración de la cateterización. Still another characteristic that catheters should cover are phlebitis complications [2] which may occur in percentages above 75% of hospitalized patients [3], which means a problem in clinical treatment, patient dissatisfaction, continuous catheter replacement and prolonged hospitalization stays that increase the costs of hospitalization services. Health. One of the factors that causes phlebitis is related to the type of medication administered that can irritate the tissues in the catheterization zone. The other factors are related to infectious agents due to the growth of microorganisms between the catheter and the puncture site. In addition to mechanical factors such as the type of catheter material, site size and duration of catheterization.
Los metales oligodinámicos como la plata en forma de iones y cantidades pequeñas son muy efectivos como bactericidas. Para los catéteres intravenosos se utiliza un recubrimiento polimérico de plata en forma de colágeno el cual se disuelve una vez que el catéter se encuentra en el sistema vascular del paciente evitando así el crecimiento de microorganismos en la zona de punción. Otra soluciones similares se pueden encontrar en las patentes US 005759564A, US 006060000A y otras. El uso de metales oligodinámicos en forma de recubrimiento fluido presenta la problemática de que el recubrimiento se disuelve muy rápido y entonces ya no existe la protección antibacterial y en la mayoría de los catéteres intravenosos su estancia en el sistema vascular del paciente es de tiempo prolongado, además de que las infecciones pueden entrar al cuerpo del paciente por la parte interior o exterior del catéter y no todos los catéteres tiene recubrimiento en ambas zonas. Oligodynamic metals such as silver in the form of ions and small amounts are very effective as bactericides. For intravenous catheters, a collagen-shaped silver polymeric coating is used which dissolves once the catheter is in the patient's vascular system thus preventing the growth of microorganisms in the puncture site. Other similar solutions can be found in patents US 005759564A, US 006060000A and others. The use of oligodynamic metals in the form of a fluid coating presents the problem that the coating dissolves very quickly and then there is no longer antibacterial protection and in most intravenous catheters their stay in the patient's vascular system is prolonged, In addition to the fact that infections can enter the patient's body through the inside or outside of the catheter and not all catheters are coated in both areas.
Como se puede inferir en el texto la combinación de todas estas características para el diseño de catéteres intravenosos limita los materiales disponibles para su elaboración. La patente que se presenta reclama las soluciones a las necesidades de a) un catéter intravenoso de bajo coeficiente de fricción para reducir el daño a los tejidos de paciente durante su colocación y así mismo la sensación de dolor, b) un catéter elaborado de materiales con características antibacteriales que actúen el interior y exterior del catéter reduciendo la posibilidad de flebitis, c) un catéter con propiedades mecánicas que faciliten su colocación evitando problemas de floreo y arremangado del catéter y d) un catéter intravenoso con características de radio-opacidad. OBJETIVOS DE LA INVENCIÓN As can be inferred in the text, the combination of all these characteristics for the design of intravenous catheters limits the materials available for their elaboration. The patent presented claims solutions to the needs of a) a low friction coefficient intravenous catheter to reduce damage to the patient's tissues during placement and also the sensation of pain, b) a catheter made of materials with antibacterial characteristics that act inside and outside the catheter reducing the possibility of phlebitis, c) a catheter with mechanical properties that facilitate its placement avoiding problems of flourishing and roll-up of the catheter and d) an intravenous catheter with radio-opacity characteristics. OBJECTIVES OF THE INVENTION
El principal objetivo de la invención es lograr un catéter intravenoso que presente bajo coeficiente de fricción con la piel y la vena del paciente de manera que se reduzca al mínimo el daño en los tejidos generado por la punción y colocación del catéter. The main objective of the invention is to achieve an intravenous catheter that has a low coefficient of friction with the patient's skin and vein so as to minimize tissue damage caused by puncture and placement of the catheter.
Otro de los objetivos es lograr un catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas, que además evite el crecimiento de agentes bacteriales causante de infecciones o flebitis. Another objective is to achieve an intravenous catheter made of polymer composite material reinforced with nanoparticles oriented in specific directions, which also prevents the growth of bacterial agents causing infections or phlebitis.
Aun otro objetivo es un catéter intravenoso que presente las propiedades mecánicas necesarias para evitar los fenómenos de arremangado y floreo del catéter cuando se realiza la punción y su colocación en el sistema vascular del paciente y tenga suficiente flexibilidad para adaptarse a la forma y movimientos de la vena durante su tiempo de uso. Still another objective is an intravenous catheter that presents the mechanical properties necessary to avoid the phenomena of roll up and flourish of the catheter when the puncture is performed and its placement in the vascular system of the patient and has sufficient flexibility to adapt to the shape and movements of the vein during its time of use.
Y todos aquellos objetivos y ventajas que se harán aparentes con la lectura acompañada de los dibujos que con fines ilustrativos, más no limitativos, forman parte integral de la presente descripción. And all those objectives and advantages that will become apparent with the reading accompanied by the drawings that for illustrative purposes, but not limitation, are an integral part of this description.
BREVE DESCRIPCIÓN DEL INVENTO BRIEF DESCRIPTION OF THE INVENTION
Esta invención se refiere a un catéter intravenoso para la administración de medicamentos o fluidos al sistema vascular de un paciente, particularmente se refiere a catéteres intravenosos periféricos, centrales y otros tipos de catéter que se coloquen en el sistema vascular de un paciente para la administración o retiro de fluidos. El material de elaboración del catéter se compone de un material compuesto de una matriz polimérica la cual es reforzada con nanopartículas orientadas en direcciones específicas y que se produce por medio de la inyección y/o extrusión de dicho material para la formación de una tubería que sirve como componente base para la elaboración del catéter. This invention relates to an intravenous catheter for the administration of medications or fluids to a patient's vascular system, particularly it relates to peripheral, central intravenous catheters and other types of catheters that are placed in a patient's vascular system for administration or fluid removal The catheter manufacturing material is composed of a material composed of a polymeric matrix which is reinforced with nanoparticles oriented in specific directions and which is produced by means of the injection and / or extrusion of said material for the formation of a pipe that serves as a base component for catheter fabrication.
Esta invención se refiere a un dispositivo médico que cumple con las características de ser un catéter que por sus propiedades mecánicas y de acuerdo cal tipo de orientación de las nanopartículas, evita los fenómenos de arremangado y floreo de la punta del catéter que se introduce en la vena del paciente al atravesar la piel por medio del corte de una aguja introductora, además de ser un catéter que por la composición del material que lo forma posee bajos coeficientes de fricción entre su exterior y la piel puncionada cuando este se coloca el sistema vascular del paciente. This invention relates to a medical device that meets the characteristics of be a catheter for their mechanical and according c to the type of orientation properties of nanoparticles, avoids phenomena arremangado and flourish of the catheter tip that is inserted into the vein of the patient through the skin by cutting a introducer needle, in addition to being a catheter that due to the composition of the material that forms it has low coefficients of friction between its exterior and the punctured skin when the patient's vascular system is placed.
Así mismo el material del cual está formado el catéter posee la característica de ser un material que evita el crecimiento de agentes infecciosos en la zona de cateterización del paciente evitando la generación de flebitis y las problemáticas relacionadas con este padecimiento. Likewise, the material from which the catheter is formed has the characteristic of being a material that prevents the growth of infectious agents in the area of catheterization of the patient avoiding the generation of phlebitis and the problems related to this condition.
El catéter de material compuesto polimérico con nanopartículas orientadas, de bajo coeficiente de fricción y baja adherencia microbiana de esta invención se compone de una tubería elaborada de material polimérico biocompatible al cual se le agrega durante su procesamiento un porcentaje de nano partículas biocompatibles que van en rangos del 10 al 50 por ciento del total de material procesado. Las nanopartículas se encuentran en rangos de tamaños mayores a 1 nm y orientadas en direcciones específicas, dentro del material polimérico por medios físicos, de manera que la tubería resultante es de un material compuesto polimérico con nano partículas orientadas en direcciones específicas. The polymer composite composite catheter with oriented nanoparticles, low coefficient of friction and low microbial adhesion of this invention is composed of a pipe made of biocompatible polymeric material to which a percentage of biocompatible nano particles that range in ranges are added during processing 10 to 50 percent of the total material processed. The nanoparticles are in ranges of sizes greater than 1 nm and oriented in specific directions, within the polymeric material by physical means, so that the resulting pipe is of a polymeric composite material with nano particles oriented in specific directions.
La tubería que forma el catéter se corta en tramos que van de rangos de longitud mayores a 1 cm, donde la parte distal de tubería de catéter se forma por medios físicos en geometrías determinadas de acuerdo al tipo de procedimiento médico para el cual se aplicará; mientras que en la parte anterior del catéter se une un componente que permite el acoplamiento con las tuberías de suero para la administración de medicamento, con dispositivos para la extracción de fluidos y otros relacionados con los procedimientos de cateterización. The pipe that forms the catheter is cut into sections that range in lengths greater than 1 cm, where the distal part of the catheter pipe is formed by physical means in determined geometries according to the type of medical procedure to which it will be applied; while in the anterior part of the catheter a component is attached that allows the coupling with the serum tubes for the administration of medication, with devices for the extraction of fluids and others related to catheterization procedures.
La tubería base para elaboración del catéter se puede formar en rangos de diámetro exterior mayores a 0.1 mm y se puede formar en rangos diámetro interno mayores a 0.1 mm. La orientación de las nanopartículas en el material compuesto polimérico cumplen con dos funciones principales; la primera es brindarle al catéter resistencia mecánica al floreo y arremangado durante el proceso de punción y canalización, además de brindar al catéter flexibilidad para deformarse en función del movimiento de la vena del paciente cuando este ya se ha colocado. The base pipe for catheter fabrication can be formed in ranges of outside diameter greater than 0.1 mm and can be formed in ranges of internal diameter greater than 0.1 mm. The orientation of the nanoparticles in the polymer composite material meet with two main functions; The first is to provide the catheter with mechanical resistance to flourish and roll up during the puncture and canalization process, in addition to providing the catheter with flexibility to deform depending on the movement of the patient's vein when it has already been placed.
La segunda función principal consiste en que de acuerdo a tipo de nanopartículas seleccionadas y el tipo de orientación le proporcionan al catéter bajos coeficientes de fricción con la piel y vena del paciente además de ser nanopartículas con propiedades bactericidas evitando de esta forma la formación de agentes infecciosos en la zona de cateterización. Aún más las nanopartículas tienen propiedades de radiopacidad. The second main function is that according to the type of nanoparticles selected and the type of orientation they provide the catheter with low coefficients of friction with the patient's skin and vein, in addition to being nanoparticles with bactericidal properties, thus preventing the formation of infectious agents. in the catheterization zone. Even more nanoparticles have radiopacity properties.
BREVE DESCRIPCIÓN DE FIGURAS BRIEF DESCRIPTION OF FIGURES
La Fig. 1 ilustra una vista en ísométrico del catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas. Fig. 1 illustrates an isometric view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions.
La Fig. 2 muestra una vista de sección lateral del catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas. Fig. 2 shows a side sectional view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions.
La Fig. 3 ilustra una vista de la sección transversal del catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas. Fig. 3 illustrates a cross-sectional view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions.
La Fig. 4 muestra una vista de sección lateral de una de las posibles configuraciones de la punta distal del catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas. DESCRIPCIÓN DETALLADA DE LA INVENCIÓN Fig. 4 shows a side sectional view of one of the possible configurations of the distal tip of the intravenous catheter made of polymeric composite material reinforced with nanoparticles oriented in specific directions. DETAILED DESCRIPTION OF THE INVENTION
Para la descripción detallada, nos apoyaremos en las figuras de la modalidad preferida de la presente invención. Una vista en isométrico del catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas se muestra en la figura 1. La tubería (1) elaborada de material compuesto polimérico reforzado con nanopartículas, se encuentra unida a un cubo o pabellón (2) que sirve como acoplamiento a sistemas de infusión intravenosos u otros dispositivos en función de la aplicación particular del catéter, además la parte anterior de la tubería (1) se forma por medios físicos en geometrías especificas (1 1) en función de la aplicación particular del catéter. Como se representa en la figura 1 la tubería (1) se coloca dentro del cuerpo del paciente en las zonas de tratamiento mientras que el pabellón (2) queda en el exterior para ser acoplado a los sistemas de infusión u otros dispositivos médicos necesarios para el tratamiento en específico. For the detailed description, we will rely on the figures of the preferred embodiment of the present invention. An isometric view of the intravenous catheter made of polymeric composite material reinforced with nanoparticles oriented in specific directions is shown in Figure 1. The pipe (1) made of polymeric composite material reinforced with nanoparticles, is attached to a hub or canopy (2 ) which serves as a coupling to intravenous infusion systems or other devices depending on the particular application of the catheter, in addition the anterior part of the pipe (1) is formed by physical means in specific geometries (1 1) depending on the particular application of the catheter As shown in figure 1 the pipe (1) is placed inside the patient's body in the treatment areas while the pavilion (2) is outside to be coupled to the infusion systems or other medical devices necessary for the specific treatment
Las capas que forman la tubería del catéter (1) intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas se muestran en la vista de sección lateral de la figura 2. En el interior de la tubería existe un hueco o lumen (14) por donde circulan los fluidos a través del catéter, este lumen (14) se puede formar en diámetros de rangos mayores a 0.1 mm. The layers that form the intravenous catheter pipe (1) made of polymer composite material reinforced with nanoparticles oriented in specific directions are shown in the side sectional view of Figure 2. Inside the pipe there is a gap or lumen (14 ) where the fluids circulate through the catheter, this lumen (14) can be formed in diameters of ranges greater than 0.1 mm.
La pared de lumen (13) se forma del material polimérico compuesto reforzado con nanopartículas, las cuales se orientan en direcciones con ángulos de orientación entre 0 y 360 grados y con una concentración en la matriz de polímero con rangos entre el 10 y 50 % de partículas reforzantes. En la superficie externa de la pared del lumen existe un recubrimiento (12) elaborado de partículas con propiedades bactericidas y coeficientes de fricción menores a 0.9. El recubrimiento (12) se encuentra difundido con la superficie de la pared de lumen (13) formado un segundo compuesto que representa la superficie de la tubería del catéter (1). The lumen wall (13) is formed of the composite polymeric material reinforced with nanoparticles, which are oriented in directions with orientation angles between 0 and 360 degrees and with a concentration in the polymer matrix with ranges between 10 and 50% of reinforcing particles. On the outer surface of the lumen wall there is a coating (12) made of particles with bactericidal properties and friction coefficients of less than 0.9. The coating (12) is diffused with the surface of the lumen wall (13) formed a second compound representing the surface of the catheter pipe (1).
Una vista de la sección transversal del catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas se muestra en la figura 3. Se indican las capas que forman la tubería del catéter (1) que presenta diámetros internos o lumen (14) en rangos mayores a 0.1 mm y diámetros externos con rangos mayores a 0.1 mm con espesores de pared de lumen (13) superiores a 0.01 mm. En la superficie exterior de la tubería del catéter (1) se aplica un recubrimiento (12) de un compuesto elaborado con materiales bactericidas y de bajo coeficiente de fricción con el objetivo de disminuir la resistencia al desplazamiento del catéter a través de los tejidos del paciente y además de evitar la adherencia y crecimiento microbiano que pueden generar infecciones. La pared de lumen (13) se refuerza con nano partículas que por medio de su orientación incrementan la resistencia de la tubería del catéter (1) en la dirección axial de la tubería e incrementa la flexibilidad en la dirección transversal de la tubería del catéter (1). Una vista de sección de la punta formada de la tubería del catéter (1) se muestra en la figura 4. La tubería formada por un lumen (14) con pared del lumen (13) recubierta en su exterior por un recubrimiento (12) en la parte anterior se forma por medios físicos mecánicos o térmicos en geometrías específicas (11) en función del tipo de tratamiento y aplicación del catéter. Una posible geometría específica (1 1) es la que se muestra en la figura 4 la cual corresponde a una geometría específica (11) características de un catéter intravenoso periférico, en la cual se pueden observar las diferentes capas que forman la tubería del catéter (1) elaborado de material compuesto polimérico reforzado con nano partículas orientadas en direcciones específicas. Referencias A cross-sectional view of the intravenous catheter made of polymer composite reinforced with nanoparticles oriented in specific directions is shown in Figure 3. The layers forming the catheter tubing (1) having internal diameters or lumen (14) are indicated. in ranges greater than 0.1 mm and external diameters with ranges greater than 0.1 mm with lumen wall thicknesses (13) greater than 0.01 mm. On the outer surface of the catheter tubing (1) a coating (12) of a compound made of bactericidal materials with low coefficient of friction is applied in order to reduce the resistance to displacement of the catheter through the patient's tissues and besides avoiding the adhesion and microbial growth that can generate infections. The lumen wall (13) is reinforced with nano particles which, through its orientation, increase the resistance of the catheter pipe (1) in the axial direction of the pipe and increase the flexibility in the transverse direction of the catheter pipe ( one). A sectional view of the tip formed of the catheter pipe (1) is shown in Figure 4. The pipe formed by a lumen (14) with a lumen wall (13) coated on its outside by a coating (12) in The anterior part is formed by mechanical or thermal physical means in specific geometries (11) depending on the type of treatment and application of the catheter. A possible specific geometry (1 1) is that shown in Figure 4 which corresponds to a specific geometry (11) characteristic of a peripheral intravenous catheter, in which the different layers that form the catheter tubing can be observed ( 1) made of polymer composite material reinforced with nano particles oriented in specific directions. References
[1.] A. M. Rivera , K. W. Strauss , A. Van Zundert, and E. Mortier, The history of peripheral intravenous catheters : How little plástic tubes revolutionized medicine, Acta Anaesth. Belg., 2005, 56, 271-282. [1.] A. M. Rivera, K. W. Strauss, A. Van Zundert, and E. Mortier, The history of peripheral intravenous catheters: How little plastic tubes revolutionized medicine, Acta Anaesth. Belg., 2005, 56, 271-282.
[2.] Sutariya B, Berk W. Vascular access. In: Tintinally J, Kelen G, Stapczynski S, eds. Emergency Medicine. 5th ed. New York: McGraw-Hill, 2000:103-4. [2.] Sutariya B, Berk W. Vascular access. In: Tintinally J, Kelen G, Stapczynski S, eds. Emergency Medicine 5th ed. New York: McGraw-Hill, 2000: 103-4.
[3.] Myrianthefs P, Sifaki M, Samara I, Baltopoulos G. The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J Eval Clin Pract 2005; 11 :85-9. El invento ha sido descrito suficientemente como para que una persona con conocimientos medios en la materia pueda reproducir y obtener los resultados que mencionamos en la presente invención. Sin embargo, cualquier persona hábil en el campo de la técnica que compete el presente invento puede ser capaz de hacer modificaciones no descritas en la presente solicitud, sin embargo, si para la aplicación de estas modificaciones en una estructura determinada o en el proceso de manufactura del mismo, se requiere de la materia reclamada en las siguientes reivindicaciones, dichas estructuras deberán ser comprendidas dentro del alcance de la invención. [3.] Myrianthefs P, Sifaki M, Samara I, Baltopoulos G. The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J Eval Clin Pract 2005; 11: 85-9. The invention has been described sufficiently that a person with average knowledge in the field can reproduce and obtain the results mentioned in the present invention. However, any skilled person in the field of the art that is in charge of the present invention may be able to make modifications not described in the present application, however, if for the application of these modifications in a given structure or in the manufacturing process thereof, the matter claimed in the following claims is required, said structures must be included within the scope of the invention.

Claims

REIVINDICACIONES Una vez descrita la presente invención, con grado de habilitación, se considera como una novedad y por ello se reclama como propiedad, lo contenido en las siguientes cláusulas: CLAIMS Once the present invention has been described, with a degree of qualification, it is considered as a novelty and therefore is claimed as property, what is contained in the following clauses:
1. Un catéter para la administración o extracción de fluidos del sistema vascular de un paciente caracterizado porque la pared de lumen (13) se forma del material polimérico compuesto reforzado con nanopartículas, las cuales se orientan en direcciones a diferentes ángulos de orientación, y con una concentración en la matriz de polímero con rangos entre el 10 y 50 % de partículas de refuerzo; en la superficie externa de la pared del lumen existe un recubrimiento (12) elaborado de partículas con propiedades bactericidas y coeficientes de fricción menores a 0.9; el recubrimiento (12) se encuentra difundido con la superficie de la pared de lumen (13) formado un segundo compuesto que representa la superficie de la tubería del catéter (1). 1. A catheter for the administration or extraction of fluids from the vascular system of a patient characterized in that the lumen wall (13) is formed of the composite polymeric material reinforced with nanoparticles, which are oriented in directions at different orientation angles, and with a concentration in the polymer matrix with ranges between 10 and 50% of reinforcing particles; on the outer surface of the lumen wall there is a coating (12) made of particles with bactericidal properties and friction coefficients of less than 0.9; The coating (12) is diffused with the surface of the lumen wall (13) formed a second compound representing the surface of the catheter pipe (1).
2. Un catéter para la administración o extracción de fluidos del sistema vascular de un paciente, tal y como se reclama en la reivindicación anterior, caracterizado porque se elabora de un material polimérico reforzado con nanopartículas las cuales se orientan en direcciones específicas de acuerdo a la aplicación del catéter y que además presenta bajo coeficiente de fricción con los tejidos del paciente cuando es colocado. 2. A catheter for the administration or extraction of fluids from the vascular system of a patient, as claimed in the preceding claim, characterized in that it is made of a polymeric material reinforced with nanoparticles which are oriented in specific directions according to the catheter application and also has a low coefficient of friction with the patient's tissues when placed.
3. Un catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas, tal y como se reclama en la reivindicación 1 , caracterizado además porque se forma con un diámetro interior o lumen (14) con tamaño mayor a 0.1 mm. 3. An intravenous catheter made of polymer composite material reinforced with nanoparticles oriented in specific directions, as claimed in claim 1, further characterized in that it is formed with an inner diameter or lumen (14) with a size greater than 0.1 mm.
4. Un catéter intravenoso elaborado de material compuesto polimérico reforzado con nanopartículas orientadas en direcciones específicas, tal y como se reclama en la reivindicación anterior, caracterizado además porque el extremo distal de la tubería del catéter (1) se forma en geometrías especificas (1 1) de acuerdo a la aplicación del catéter y porque en el extremo anterior se une un cubo o pabellón (2) que sirve para la conexión para los sistemas de administración y extracción de fluidos o dispositivos médicos relacionados con el tratamiento en particular que se aplica. 4. An intravenous catheter made of polymer composite material reinforced with nanoparticles oriented in specific directions, as claimed in the preceding claim, further characterized in that the distal end of the catheter tubing (1) is formed in specific geometries (1 1 ) according to the application of the catheter and because at the anterior end a cube or pavilion (2) is attached that it is used for the connection for the administration and extraction systems of fluids or medical devices related to the particular treatment that is applied.
PCT/MX2014/000032 2013-01-30 2014-01-29 Intravenous catheter of a polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence WO2014119987A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2013001220A MX2013001220A (en) 2013-01-30 2013-01-30 Intravenous catheter of a polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence.
MXMX/A/2013/001220 2013-01-30

Publications (1)

Publication Number Publication Date
WO2014119987A1 true WO2014119987A1 (en) 2014-08-07

Family

ID=51262627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2014/000032 WO2014119987A1 (en) 2013-01-30 2014-01-29 Intravenous catheter of a polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence

Country Status (2)

Country Link
MX (1) MX2013001220A (en)
WO (1) WO2014119987A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026532A2 (en) * 2001-09-28 2003-04-03 Boston Scientific Limited Medical devices comprising nanomaterials and therapeutic methods utilizing the same
WO2005115496A1 (en) * 2004-05-20 2005-12-08 Boston Scientific Scimed, Inc. Medical devices having multiple layers
WO2006100156A2 (en) * 2005-03-24 2006-09-28 Nolabs Ab Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide
WO2007056058A2 (en) * 2005-11-03 2007-05-18 Paragon Intellectual Properties, Llc Radiopaque-balloon microcatheter and methods of manufacture
US20110264080A1 (en) * 2010-04-23 2011-10-27 Sukgyung AT Co., Ltd. Medical Devices Having Extremely High Radiopacity Containing Ytterbium Compound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026532A2 (en) * 2001-09-28 2003-04-03 Boston Scientific Limited Medical devices comprising nanomaterials and therapeutic methods utilizing the same
WO2005115496A1 (en) * 2004-05-20 2005-12-08 Boston Scientific Scimed, Inc. Medical devices having multiple layers
WO2006100156A2 (en) * 2005-03-24 2006-09-28 Nolabs Ab Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide
WO2007056058A2 (en) * 2005-11-03 2007-05-18 Paragon Intellectual Properties, Llc Radiopaque-balloon microcatheter and methods of manufacture
US20110264080A1 (en) * 2010-04-23 2011-10-27 Sukgyung AT Co., Ltd. Medical Devices Having Extremely High Radiopacity Containing Ytterbium Compound

Also Published As

Publication number Publication date
MX2013001220A (en) 2014-07-30

Similar Documents

Publication Publication Date Title
JP5330373B2 (en) catheter
ES2373241T3 (en) CATHETERS INCLUDING AN ANTIMICROBIAL HOSE AND METHODS OF MANUFACTURING CATHETERS.
ES2435844T3 (en) Luer antimicrobial adapter
US4623329A (en) Drainage and infusion catheters having a capillary sleeve forming a reservoir for a fluid antimicrobial agent
ES2929402T3 (en) Antimicrobial Coated Catheter
KR102595041B1 (en) Catheter system for continuous irrigation
ES2282529T3 (en) COMPOSITION FOR THE PREVENTION OF AN INFECTION DUE TO A PERMANENT DEVICE.
JP2013500125A (en) Improved drainage device and / or catheter with retractable sleeve and method of using the same
CN106075698B (en) Drug releasing medical catheters, tubes and devices
JP2013501572A (en) CATHETER HAVING HYDRAULIC FLUID STORAGE LOCATION AND / OR CATHETER PACKAGE USING THE CATHETER AND METHOD FOR PRODUCING AND / OR USING THE CATHETER
ES2589562T3 (en) Access element and system for catheterization of the urinary bladder
JP5713732B2 (en) Catheter with valve
AU2006227766A1 (en) Wire guides having novel outer surface areas and reservoirs for enhancing hydrophilic properties and delivering therapeutic agents
BR112014004434B1 (en) BIOCOMPATIBLE CATHETER
JP4906408B2 (en) Indwelling catheter
NZ578314A (en) Tube for enteral nutrition
WO2014119987A1 (en) Intravenous catheter of a polymer compound material with oriented nanoparticles, with low friction coefficient and low microbial adherence
US10406321B1 (en) Method and apparatus for insertion of a catheter with a proximal connector while monitoring blood pressure
US8308674B1 (en) Methods and systems for multifunction needle/catheter devices
WO2015156658A1 (en) Hydrophobic texturised foley catheter with low microbial adhesion
Twardowski et al. Swan neck peritoneal dialysis catheters
JP5063137B2 (en) Indwelling method for indwelling catheter
ES2327588B1 (en) EXTRA-LONG VASCULAR INTRODUCTION CATHETER.
Nourbakhsh et al. How to care for implanted ports
Aal et al. Fluoroscopic Guided Percutaneous Insertion of PD Catheters

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14746279

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14746279

Country of ref document: EP

Kind code of ref document: A1